How to Get OJK Approval for Insurance Products in Indonesia (2026): Requirements, Timeline and Common Pitfalls

Last updated: September 2026

OJK insurance product approval Indonesia has become significantly more demanding in recent years, as the Otoritas Jasa Keuangan sharpens its focus on product governance, consumer disclosure and standardised actuarial submissions. For heads of product, compliance officers and general counsel at insurers and insurtechs, the practical challenge is no longer simply obtaining a green light, it is assembling a defensible, well-documented filing that survives closer technical scrutiny on the first pass. This guide sets out the scope of OJK approval, the end-to-end process, realistic timelines, the documentation checklist, insurtech-specific expectations, and the most common reasons filings are rejected, with remediation steps for each. Read it as a working roadmap for launching or modifying insurance products in Indonesia under current regulatory expectations.

What is OJK approval for insurance products, and when is it required?

OJK approval, or, depending on the product class, a registration/notification with OJK, is the formal regulatory step an insurer must complete before it may market and sell a new insurance product, or before it implements a material change to an existing one. The requirement flows from Indonesia’s supervisory framework for the insurance sector and is administered by the Otoritas Jasa Keuangan, the integrated financial services authority responsible for insurance, banking and capital markets. In practice, OJK insurance product approval Indonesia covers not only wholly new products but also significant modifications to coverage, pricing methodology, riders and distribution channels.

Not every change triggers the same procedure. Some adjustments may fall under a lighter notification or registration regime, while genuinely new products or material changes require fuller review. The distinction between notification and formal approval matters commercially, because it determines both the documentation burden and the time to market. When in doubt, treat a change as approval-triggering until the applicable sector rules confirm otherwise.

Legal basis for OJK insurance product approval Indonesia

The statutory foundation is Undang-Undang Republik Indonesia Nomor 40 Tahun 2014 tentang Perasuransian (the Insurance Law), which establishes OJK’s authority over the licensing, conduct and prudential supervision of insurance undertakings in Indonesia. This is complemented by Undang-Undang Nomor 4 Tahun 2023 tentang Pengembangan dan Penguatan Sektor Keuangan (the Financial Sector Development and Strengthening Law, commonly known as the P2SK Law), which amended aspects of the financial services framework. Beneath the statutes sits a layer of OJK regulations (Peraturan OJK, or POJK) and circulars (Surat Edaran OJK, or SEOJK) that set out the detailed rules on product approval, product governance, actuarial standards and consumer protection.

These instruments are published in the OJK legal document repository (JDIH OJK), and any serious filing team should verify the exact POJK and SEOJK numbers applicable to its product class before submission, as the instruments are periodically updated.

Examples of triggers requiring approval

Understanding what counts as a trigger prevents costly launch delays. The following commonly require OJK approval or, at minimum, formal engagement with the regulator:

• New products. Any product not previously approved, including new life, health or general lines.
• Pricing or formula changes. Revisions to premium rates, the underlying pricing formula, or key actuarial assumptions.
• New coverage or benefits. Additional insured perils, new riders, or expanded benefit structures.
• New distribution methods. Launching digital distribution, embedded insurance, or a new bancassurance arrangement for an existing product.
• Material wording changes. Amendments to exclusions, definitions or claims conditions that alter the risk profile or consumer position.

Because distribution changes can independently trigger review, an insurer moving an approved product from an agency channel to an insurtech platform should not assume the existing approval carries over unchanged.

Overview of the OJK approval process for insurance products

The OJK approval process for insurance products follows a broadly predictable sequence: internal readiness and governance sign-off, formal submission, technical review, response to regulator queries, and a final decision or acknowledgement. The quality of the first two stages largely determines how smoothly the later stages run. A filing that arrives complete, internally consistent and well-evidenced attracts fewer queries and clears faster.

Pre-filing readiness and internal approvals (PGC evidence)

Before anything reaches OJK, the product must pass through the insurer’s own governance. Product governance OJK expectations are pronounced: the regulator wants evidence that a properly constituted product governance function reviewed the product, considered the target market, assessed value for money, and documented its decision. Prepare the governance minutes, the conflicts-of-interest disclosures, the target-market assessment and the sign-offs from actuarial, legal, compliance and risk functions. Treat these as filing exhibits, not internal housekeeping, OJK increasingly asks to see them.

Submission to OJK

Filings are made to OJK through its designated channels for the non-bank financial industry (IKNB) supervisory function, which oversees insurance. Assemble the complete document set in the required formats, cross-referenced and consistently labelled, before you submit. A single submission containing the policy wording, actuarial memorandum, governance evidence, distribution materials and consumer disclosures is far stronger than a piecemeal filing. Confirm the current submission route and technical specifications on the OJK portal at the time of filing, as procedural details are updated from time to time.

Post-submission: queries, resubmissions and decision

After submission, OJK’s technical reviewers assess the file and typically issue written queries where information is missing, inconsistent or unclear. Each query cycle extends the timeline, so responsiveness is critical. Respond with a structured resubmission that references the query, provides the corrected documents, and includes a short remediation memo explaining what changed and why. Once the reviewers are satisfied, OJK issues its decision or acknowledgement. A clean file with prompt, complete responses is the single biggest lever on total elapsed time.

Timeline: how long does OJK insurance product approval take?

There is no single answer, because the OJK approval process for insurance products scales with product complexity, the completeness of the initial filing, and how many query cycles the review generates. As a working planning assumption, treat straightforward products as clearing faster and complex or novel products, particularly insurtech and bundled offerings, as taking longer. The ranges below are practical planning estimates rather than guaranteed service levels; always confirm current procedural expectations and any statutory service standards with OJK for your specific product class.

Typical timelines by product type

• Standard products (life, health, general). Plan for a review period of several weeks for a well-prepared filing, extending if the actuarial basis or wording attracts queries.
• Simplified and microinsurance products. These low-premium, low-complexity products can move faster where the underwriting and pricing are transparent.
• Insurtech and embedded products. Expect the longest lead time, because reviewers scrutinise data usage, digital consent, dynamic pricing and distribution oversight in addition to the core actuarial and wording review.

The most reliable way to compress the timeline is to reduce query cycles. Every incomplete or inconsistent element in the initial filing invites a query, and each query round adds days or weeks. Front-loading effort into a complete, internally consistent submission almost always beats submitting early and iterating under regulatory pressure.

Required documents and filing checklist for insurance product filing Indonesia

A robust insurance product filing Indonesia rests on a complete, well-organised document set. Group your materials by category so reviewers can navigate the file efficiently. The core categories are legal and corporate documents, the product file, the actuarial submission, and governance and distribution evidence. Each supporting document should be current, signed where required, and prepared in Bahasa Indonesia, the absence of Indonesian-language documentation is a recurring cause of rejection.

Core product file: policy wording, definitions, terms and conditions

The heart of any insurance policy approval Indonesia is the policy wording. Submit the full policy document, including the schedule, definitions, insuring clauses, exclusions, claims procedures and cancellation terms. Definitions must be precise and internally consistent, ambiguity here is one of the most common grounds for OJK queries. Exclusions must be clear and compliant, and must not conflict with the benefits described elsewhere in the wording or in the sales materials. Where a product uses technical or medical terms, ensure they are defined in plain language accessible to consumers. Consistency between the wording, the benefit illustrations and the marketing collateral is essential; reviewers read these documents against one another and flag any divergence.

Actuarial submission: pricing memorandum, assumptions and solvency testing

The actuarial file is where technically sophisticated filings distinguish themselves. OJK expects a pricing memorandum that sets out the premium basis, the underlying assumptions, and the rationale for each. For non-actuaries on the filing team, the key point is that the regulator is testing whether the pricing is sound, sustainable and justified, not merely stated. The submission should typically include:

• Pricing memorandum. A clear explanation of how premiums were derived, with the pricing formula documented.
• Key assumptions. Mortality, morbidity, lapse, expense and investment assumptions, each with a stated source and justification.
• Sensitivity and stress testing. Analysis showing how the product performs under adverse scenarios, supporting solvency and sustainability.
• Reserving basis. The approach to technical reserves and its consistency with prudential requirements.
• Actuarial model file. Where required, the supporting model spreadsheet so reviewers can trace the calculations.

Standardised, transparent actuarial documentation is an OJK priority. Vague assumptions, unexplained pricing, or a memorandum that cannot be reconciled with the model file will generate queries and delay. Where required, the appointed actuary’s certification should accompany the file. Verify the current actuarial content requirements against the applicable POJK in the JDIH OJK repository before finalising the file.

Governance and distribution evidence: governance minutes, contracts and platform security

The governance and distribution package demonstrates that the product has been properly overseen and will be responsibly sold. This is where product governance OJK expectations bite hardest. Include the governance minutes evidencing product review and approval, the conflicts-of-interest disclosures, and the target-market assessment. For distribution, provide the distribution agreements, evidence of oversight arrangements over intermediaries, and, for any digital channel, documentation of platform security and data-handling controls. For insurance distribution approval Indonesia through partners, OJK will want to see that the insurer retains genuine control and accountability over how the product is sold, not merely a contract that outsources responsibility.

Prepare the checklist in advance and use it to confirm completeness before submission. Confirm the required file formats, typically PDF for legal and policy documents and spreadsheet formats for actuarial models, and ensure every document is legible, signed where required and correctly labelled.

Insurtech and digital distribution: special considerations

Digital products introduce a distinct layer of scrutiny. Insurtech product approval Indonesia is not simply a standard filing with a website attached; OJK examines how technology shapes the customer journey, how data is collected and used, and how the insurer supervises third-party platforms. Product heads planning API-based or embedded distribution should build the technology and consent evidence into the filing from the outset rather than treating it as an afterthought.

APIs, UX disclosures and digital consent

Where a product is sold through an API integration or embedded in a partner’s checkout flow, the consumer experience becomes part of the compliance picture. OJK expects that key disclosures, coverage, exclusions, premiums, cancellation rights, are presented clearly within the digital journey, not buried in linked documents the consumer is unlikely to read. Consent must be genuine and specific: a consumer buying embedded insurance should understand what they are purchasing and affirmatively agree to it. Screenshots or a walkthrough of the digital user experience are useful filing exhibits, demonstrating that disclosures are prominent and that consent is properly captured before coverage binds.

Proof of tech controls and vendor oversight

For digital and embedded products, reviewers look for evidence of technology governance and vendor oversight. Document your platform security controls, data-handling practices and the arrangements that keep customer data protected. Personal data processing must comply with Undang-Undang Nomor 27 Tahun 2022 tentang Pelindungan Data Pribadi (the Personal Data Protection Law), including any cross-border data transfer considerations. Equally important is oversight of technology vendors and distribution partners: OJK wants assurance that the insurer monitors and can intervene in how partners deploy the product. Vendor contracts, service-level terms and audit rights all support the case that the insurer remains accountable throughout the digital distribution chain.

Can an insurer market or soft-launch before OJK approval?

This is one of the most frequently misjudged questions in insurance product filing Indonesia. The default position is cautious: an insurer generally may not sell a product, or accept premiums and bind coverage, before the applicable OJK approval or registration is in place. Doing so exposes the insurer to administrative sanctions and the risk of being ordered to withdraw materials or unwind arrangements. The distinction between marketing and selling, and between displaying and distributing, is where the practical judgment lies.

Safe pre-launch activities

Certain preparatory activities generally carry lower risk. General brand or “coming soon” announcements that do not offer a specific, purchasable product tend to be permissible. Limited, non-binding user-experience testing of a digital journey, where no premium is accepted and no coverage is created, may also be acceptable. Internal training and readiness activities are, of course, fine. The unifying principle is that nothing should create a binding insurance contract or accept consumer money before approval.

Prohibited pre-launch activities

The activities that create genuine exposure are those that amount to distribution. Accepting premiums, issuing policies, binding coverage, or otherwise concluding sales before approval are the clearest violations. Publishing detailed product-specific marketing that solicits purchase of an unapproved product also carries risk. Because the line between permitted announcement and prohibited solicitation can be fine, confirm the current pre-marketing rules in the applicable OJK regulations and circulars before running any pre-launch campaign, and keep a documented rationale for why each activity sits on the safe side of the line.

Common pitfalls and how to avoid or reverse a rejection

Most rejections and lengthy query cycles stem from a recognisable set of problems. Anticipating them is the surest route to a first-pass approval. The most frequent issues, with their remediation, are:

• Incomplete actuarial file. Missing assumptions or unexplained pricing. Remediation: provide a full pricing memorandum with sourced, justified assumptions and reconciled model file.
• Vague policy definitions. Ambiguous terms that invite dispute. Remediation: tighten definitions and ensure consistency across the wording.
• Insufficient governance evidence. No documented product governance review. Remediation: convene and minute a proper governance assessment before filing.
• Conflicting sales materials. Marketing that overstates or diverges from the policy wording. Remediation: reconcile all collateral against the approved wording.
• Non-compliant exclusions. Exclusions that undermine core benefits or breach consumer-protection rules. Remediation: revise exclusions for clarity and compliance.
• Missing Indonesian-language documents. Filing materials not in Bahasa Indonesia. Remediation: provide complete, accurate Indonesian versions.
• Unclear distribution oversight. Weak evidence of control over intermediaries. Remediation: document oversight arrangements and audit rights.
• Inadequate data-privacy consents. Especially for digital products. Remediation: strengthen consent capture and disclosure in the customer journey.
• Non-standard commission disclosures. Opaque remuneration arrangements. Remediation: disclose commission structures clearly.
• Incorrect product classification. Misclassified products. Remediation: confirm the correct classification against sector rules before filing.

How to respond to an OJK query

When OJK raises a query, treat the response as a mini-filing in its own right. Respond promptly, delay only lengthens the overall timeline. Structure the response so it maps directly to the query: reference the specific point raised, attach the corrected or supplementary documents, and provide a concise remediation memo that explains what changed and why the change resolves the concern. Where documents have been revised, supplying a tracked-changes version alongside a clean copy helps reviewers verify the fix quickly. A disciplined, well-organised query response frequently converts a stalled filing into an approval without a further round of correspondence.

Comparison: standard, simplified and insurtech filings

Different product types face different documentation burdens, timelines and areas of regulatory concern. The table below summarises the practical differences to help you scope a filing before you begin. Treat the timelines as broad planning estimates rather than guarantees, and confirm current procedural expectations with OJK.

The comparison underlines a simple planning point: the more novel the distribution model, the earlier the technology, data and governance evidence must be built. A microinsurance filing can be lean and fast; an embedded insurtech filing needs a broader evidence base and a longer runway.

Practical checklist and sample timeline for OJK insurance product approval Indonesia

Before filing, work through a consolidated checklist covering corporate and legal documents, the core product file, the actuarial submission, governance and distribution evidence, consumer disclosures and sample sales materials. A one-page sample timeline, mapping internal governance sign-off, submission, the query window and the expected decision, helps align product, actuarial, legal and compliance teams around a realistic launch date. Building in contingency for at least one query cycle is prudent, particularly for insurtech and bundled products where review is deepest. For the insurance product registration Indonesia workflow, the discipline of a shared checklist and timeline is often the difference between a launch that holds its date and one that slips.

Conclusion

OJK insurance product approval Indonesia rewards preparation, documentation quality and genuine governance. The regulator’s sharpened focus on product governance, transparent actuarial submissions and clear consumer disclosure means that filings which are complete, internally consistent and well-evidenced move faster and face fewer queries, while thin or inconsistent filings stall. Whether you are launching a standard product, a simplified microinsurance offering or an embedded insurtech product, the same principles apply: constitute and minute your product governance function, build a defensible actuarial file, align every document, and evidence your control over distribution. Approached this way, the path to a compliant approval is demanding but navigable, and a disciplined filing protects both your launch date and your standing with the regulator.

Because the applicable POJK, circulars and procedural details are periodically updated, verify the current requirements for your product class in the JDIH OJK repository before filing.

Sources

1. Otoritas Jasa Keuangan (OJK), official site
2. JDIH OJK, OJK Legal Document Repository
3. Peraturan.go.id, Indonesian legislation database (including UU No. 40 Tahun 2014 and UU No. 4 Tahun 2023)
4. Mahkamah Agung Republik Indonesia (Supreme Court)